Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostatic Neoplasms/Diagnosis”

6,556 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 6,556 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT05778097
What this trial is testing

Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study)

Who this might be right for
Prostate CancerBiochemical RecurrenceHigh Risk
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 103
Not applicableLooking for participantsNCT05000827
What this trial is testing

Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients

Who this might be right for
Prostate Cancer MetastaticProstate CancerLymph Node Metastases
Canisius-Wilhelmina Hospital 706
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04622761
What this trial is testing

Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome

Who this might be right for
Prostate Cancer
The Clatterbridge Cancer Centre NHS Foundation Trust 120
Testing effectiveness (Phase 2)Looking for participantsNCT06636682
What this trial is testing

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate CAProstate Cancers+4 more
Cellvax Therapeutics Inc 100
Early research (Phase 1)Study completedNCT00987376
What this trial is testing

Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration

Who this might be right for
Prostate Cancer
Mayo Clinic 8
Testing effectiveness (Phase 2)Looking for participantsNCT06288113
What this trial is testing

Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial

Who this might be right for
Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
Jonsson Comprehensive Cancer Center 40
Not applicableLooking for participantsNCT04751435
What this trial is testing

Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

Who this might be right for
Educational Materials for Genetic TestingBreast CancerOvarian Cancer+3 more
Memorial Sloan Kettering Cancer Center 445
Not applicableStudy completedNCT04130776
What this trial is testing

4Kscore Using Serum Stored Uncentrifuged

Who this might be right for
Prostate Cancer
OPKO Health, Inc. 64
Not applicableUnknownNCT02783079
What this trial is testing

Insomnia Interventions in Cancer Survivors

Who this might be right for
Insomnia
The Cooper Health System 210
Early research (Phase 1)Study completedNCT01414296
What this trial is testing

Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Progenics Pharmaceuticals, Inc. 10
Not applicableStudy completedNCT06299046
What this trial is testing

Bleeding After Robot-assisted Radical Prostatectomy: a Respective Study

Who this might be right for
Prostate CancerBleedingProstate Adenocarcinoma
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 194
Not applicableStudy completedNCT02353715
What this trial is testing

Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing

Who this might be right for
Prostate Cancer
Duke University 38
Early research (Phase 1)Ended earlyNCT00629876
What this trial is testing

A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.

Who this might be right for
Anemia
Takeda 2
Not applicableUnknownNCT02759380
What this trial is testing

Can Dietary Phytoestrogens Slow Down Prostate Tumor Proliferation?

Who this might be right for
Prostate Cancer
Sahlgrenska University Hospital 240
Not applicableLooking for participantsNCT06355076
What this trial is testing

New Urethral Reconstruction in Robot-assisted Laparoscopic Radical Resection

Who this might be right for
Prostate Cancer
Qilu Hospital of Shandong University 94
Testing effectiveness (Phase 2)Ended earlyNCT03432897
What this trial is testing

BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes

Who this might be right for
Prostate CancerAdenocarcinoma of the Prostate
Brown University 1
Testing effectiveness (Phase 2)Ended earlyNCT04423913
What this trial is testing

Safety, Tolerability, Distribution & Dose Effect of Neoadjuvant Transarterial Chemoembolization With Doxorubicin in Prostate Cancer Patients Before Radical Prostatectomy

Who this might be right for
Prostate Cancer
Centre Hospitalier Universitaire de Nīmes 12
Testing effectiveness (Phase 2)Study completedNCT03910660
What this trial is testing

A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

Who this might be right for
Prostate CancerNeuroendocrine TumorsSmall Cell Carcinoma
BioXcel Therapeutics Inc 98
Not applicableEnrolling By InvitationNCT03503643
What this trial is testing

Hemi-Gland Cryoablation for Prostate Cancer at UCLA

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Disease
Jonsson Comprehensive Cancer Center 100
Testing effectiveness (Phase 2)Ended earlyNCT05712174
What this trial is testing

[18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer

Who this might be right for
OncologyProstate Cancer
AHS Cancer Control Alberta 176
Load More Results